Berberine suppresses androgen receptor signaling in prostate cancer.
about
Epithelial-to-mesenchymal transition markers to predict response of Berberine in suppressing lung cancer invasion and metastasis20(S)-protopanaxadiol-aglycone downregulation of the full-length and splice variants of androgen receptor.Prediction of novel drug indications using network driven biological data prioritization and integration.p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine.Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.Compounds from Cynomorium songaricum with Estrogenic and Androgenic Activities Suppress the Oestrogen/Androgen-Induced BPH ProcessSplicing variants of androgen receptor in prostate cancer.Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.Berberine Reduces cAMP-Induced Chloride Secretion in T84 Human Colonic Carcinoma Cells through Inhibition of Basolateral KCNQ1 Channels.20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.Methylselenocysteine preventing castration-resistant progression of prostate cancerBerberine regulates AMP-activated protein kinase signaling pathways and inhibits colon tumorigenesis in mice.Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cellsGaleterone and VNPT55 induce proteasomal degradation of AR/AR-V7, induce significant apoptosis via cytochrome c release and suppress growth of castration resistant prostate cancer xenografts in vivo.Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agentsBerberine inhibits androgen synthesis by interaction with aldo-keto reductase 1C3 in 22Rv1 prostate cancer cells.Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling.The interplay of AMP-activated protein kinase and androgen receptor in prostate cancer cells.Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancerCeritinib for treatment of ALK-rearranged advanced non-small-cell lung cancer.Systematic structure modifications of multitarget prostate cancer drug candidate galeterone to produce novel androgen receptor down-regulating agents as an approach to treatment of advanced prostate cancer.Bioactive natural products for chemoprevention and treatment of castration-resistant prostate cancer.Extract of Zuojin Pill ([characters: see text]) induces apoptosis of SGC-7901 cells via mitochondria-dependent pathway.Zyflamend, a combination of herbal extracts, attenuates tumor growth in murine xenograft models of prostate cancer.A naturally derived small molecule disrupts ligand-dependent and ligand-independent androgen receptor signaling in human prostate cancer cells.Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway.Beyond androgen deprivation: ancillary integrative strategies for targeting the androgen receptor addiction of prostate cancer.
P2860
Q21245487-9E810A05-EC78-4AC6-A2A0-EDFBEE6253A0Q30528764-D84B0975-3EDF-4AC7-9EFD-7AC806864B43Q30727519-DB92EA6A-0EFD-45B1-AB41-E35195A9A452Q33581359-D024782B-ED6D-4F59-87B7-1790A29BC291Q33688956-09921386-87F3-40CE-B121-F4EC395FB575Q33735698-DC7931E9-357D-4A21-AF89-49E973A2CE3BQ34448143-A3C56DA0-D400-427E-8543-13D33EE9177FQ34838111-81133662-AF73-4804-B49A-009CBD472720Q35084796-45364984-0D88-422B-97DE-68AB1B44089EQ35399276-ED881DE7-1C99-429D-9ED0-890AF20DE4D1Q35582612-539D800A-B8DC-465A-8395-DDE084EEF44DQ35858819-A197589F-B8B1-4140-8E36-7C2AC6C78ECFQ36377229-F754D048-7957-4A90-828C-04F431DE9BDAQ36413805-3E7D4A2F-41C0-4138-ACCD-7D6B81DE720DQ36414184-08310095-B3BC-44AA-84CB-A76EAE6EEE48Q37113190-4B9AC13D-7EBA-42BE-870D-E2CFEB04AAA1Q37134408-40A5F212-4304-4BAB-BC82-9D53E81A0627Q37626493-8EFF0850-D03B-4F6C-A482-8F5D99CB308FQ37689064-1F7FE02B-CCAB-4D8B-9EB1-FA4AF50C93B4Q38214154-95A8E52E-F46C-4934-AE5D-C6D2F128DBB3Q38361928-6170BBCA-C2F6-45E7-9792-5F4A0604D397Q38883820-C353E355-F4CF-4D4D-8078-0E97D1B25CC1Q38890242-79D69821-BD11-4F24-8729-BFEACB169C5BQ39337547-9671FF0B-78F6-4609-A1E3-C4F51A7DDB29Q42006737-475FA047-A189-43B5-A881-C24B9D4A99AAQ47164770-FF59E100-4BC2-4D1A-BE13-169C480AD3E1Q50455684-7B0DCBBF-7820-4484-8937-58706D6920E0
P2860
Berberine suppresses androgen receptor signaling in prostate cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Berberine suppresses androgen receptor signaling in prostate cancer.
@ast
Berberine suppresses androgen receptor signaling in prostate cancer.
@en
type
label
Berberine suppresses androgen receptor signaling in prostate cancer.
@ast
Berberine suppresses androgen receptor signaling in prostate cancer.
@en
prefLabel
Berberine suppresses androgen receptor signaling in prostate cancer.
@ast
Berberine suppresses androgen receptor signaling in prostate cancer.
@en
P2093
P2860
P1476
Berberine suppresses androgen receptor signaling in prostate cancer
@en
P2093
Haitao Zhang
Oliver Sartor
Xichun Liu
Zhenggang Xiong
P2860
P304
P356
10.1158/1535-7163.MCT-10-0985
P50
P577
2011-05-25T00:00:00Z